Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DeFi Technologies Subsidiary Valour Introduces World’s first Physical Yield Bearing Bitcoin (1VBS) ETP in Collaboration with Core Foundation, to German Investors on Xetra, Offering Exposure to Bitco
-
Purpose Investments Unveils New Meta and AMD Single-Stock Yield Shares ETFs in Its Acclaimed Yield Shares Suite
-
Terms for Nykredit's and Totalkredit's auctions - Nykredit Realkredit A/S
-
MIND CTI Reports Third Quarter 2024 Results
-
A New Era in DeFi: OptSwap Launches Innovative Crypto Options Trading Platform
-
HUB Security Announces Strategic Initiatives and Upcoming Financial Results Amid U.S. Market Penetration Plans
-
GRASS, a DePIN Project, Will Be Initially Listed on CoinW Exchange
-
Invesco Ltd: Form 8.3 - Anglogold Ashanti PLC; Public dealing disclosure
-
Invesco Ltd: Form 8.3 - International Paper Company; Public dealing disclosure
-
BioRestorative Therapies Receives Expanded Tissue License from New York State Department of Health
-
uniQure Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Apellis Pharmaceuticals Reports Third Quarter 2024 Financial Results
-
TransAlta Reports Strong Third Quarter 2024 Results
-
Xometry Reports Third Quarter 2024 Results
-
700Credit Industry Survey Shows the Alarming Lack Of Procedure RV Dealers Still Have In Collecting Drivers’ Licenses For Test Drives & High Susceptibility To Multiple Types Of Fraud
-
700Credit Industry Survey Shows the Alarming Lack Of Procedure RV Dealers Still Have In Collecting Drivers’ Licenses For Test Drives & High Susceptibility To Multiple Types Of Fraud
-
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Gate.io Shatters Records in Total Trading Volume in Q3 2024, with Its User Base Surpassing 17 Million
-
SpringWorks Therapeutics to Participate in Guggenheim’s Inaugural Healthcare Innovation Conference
-
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights
-
Colliers Reports Third Quarter Results
-
Sotera Health Reports Third-Quarter and Year-to-Date 2024 Results
-
Aura Minerals and Bluestone Resources Agree to Amendment to Arrangement Agreement
-
R1 RCM Reports Third Quarter 2024 Results
-
Intra-Cellular Therapies Announces Positive Topline Results in Phase 3 Trial Evaluating CAPLYTA for the Prevention of Relapse in Patients with Schizophrenia
-
Beasley Broadcast Group Reports Third Quarter Revenue of $58.2 Million
-
NeuroMetrix Reports Q3 2024 Business Highlights
-
U.S. Energy Corp. Announces Third Quarter 2024 Results Conference Call Date
-
Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
-
DLH to Provide Critical Systems Engineering and Integrated Logistics Services for Navy C5ISR Systems
-
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
-
Limitless X Announces Change of Ticker Symbol to LIMX on the OTCQB Exchange
-
Agrify Secures Financing from Green Thumb Industries and Announces New Leadership
-
LGI Homes Reports Third Quarter 2024 Results and Updates Full Year 2024 Guidance
-
Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results
-
Vigil Neuroscience to Present at Guggenheim Healthcare Innovation Conference
-
Entrada Therapeutics Reports Third Quarter 2024 Financial Results
-
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
-
TransCode Therapeutics Announces Nasdaq Extension to Regain Compliance
-
ScottsMiracle-Gro Appoints Rob Candelino to Board of Directors
-
Cullinan Therapeutics to Participate in Fireside Chat at Stifel 2024 Healthcare Conference
-
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
-
ZyVersa Therapeutics Highlights Published Data Demonstrating the Potential of Inflammasome Inhibition to Protect Pancreatic Islet Beta Cells and Attenuate Progression from Obesity to Insulin Resistanc
-
GlobalFoundries Reports Third Quarter 2024 Financial Results
-
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
-
REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Third Quarter Results
-
TransUnion to Present at Upcoming Investor Conferences in Chicago and New York
-
Endeavour Silver Announces Q3 2024 Financial Results; Earnings Call at 10AM PDT (1PM EDT) Today
-
Montage Gold Implements Revenue Protection Programme
-
Onity Group Announces Third Quarter 2024 Results
